FDA Expands Approval of Severe Asthma Drug

(MedPage Today) -- The FDA expanded the approval of benralizumab (Fasenra) to include treatment of younger kids with uncontrolled severe asthma with an eosinophilic phenotype, AstraZeneca announced on Thursday. Previously approved for individuals...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news